Lainie P. Martin, MD

Lainie Martin, MD

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

Assistant Professor

Chief, Gynecologic Medical Oncology

Research Program

Treatment Philosophy

After completing my fellowship at Fox Chase Cancer Center, I joined the medical staff in 2006. Fox Chase is a wonderful environment in which to work because of its caring team of physicians, nurses and staff. My patients frequently tell me that the community at Fox Chase Cancer Center is a source of much-needed comfort as they navigate a difficult time in their lives.

The team approach is another reason Fox Chase is so special. The close collaboration among medical oncologists, radiation oncologists, surgical oncologists, radiologists and pathologists results in the most comprehensive plan for each patient... Expand

Educational Background

  • Fellow, Hematology-Oncology, Fox Chase Cancer Center and Temple University, Philadelphia, PA
  • Resident, Internal Medicine, Boston University Medical Center, Boston, MA
  • MD, Temple University School of Medicine, Philadelphia, PA, 1999


  • American Board of Internal Medicine
  • Medical Oncology


  • American Society of Clinical Oncology
  • American College of Physicians
  • American Medical Association
  • American Medical Women's Association
  • Member, Genomic Advisory Board/Cancer Genome Institute (CGI) Advisory Committee, Fox Chase Cancer Center
  • Active Member, American Association for Cancer Research (AACR)

Tanya Dwyer

Tanya Dwyer

Tanya Dwyer was treated in 2004 for a rare type of cancer affecting younger women, called choriocarcinoma, in Philadelphia. Choriocarcinomas usually occur in the reproductive organs and develop from cells that would typically turn into eggs in a woman's uterus. These cells usually grow quickly and spread widely.

Tanya was a single working mom at the time. "Then, several years later, I found out the cancer had recurred in my lung," she recalled. "I was devastated."

Cathy Van Horn

Ovarian & Primary Peritoneal Cancer

Cathy Van Horn

Ovarian & Primary Peritoneal Cancer

When Cathy Van Horn met with her Fox Chase Cancer Center team in 2012, she knew where things stood. “I understood that my cancer wasn’t going to be cured. The best we could do was to manage my cancer and keep it at bay. The longer we could stay positive and keep moving forward, the longer I’d be here.”

Cynthia Danko

Ovarian & Primary Peritoneal Cancer

Cynthia Danko

Ovarian & Primary Peritoneal Cancer

Like most people, Cindy Danko had no time to be sick. A full time house painter, Cyd – as she’s known to her friends – was used to keeping a busy schedule packed with physically demanding work. In February 2009, shortly before her 50th birthday, Cyd went to her gynecologist for an annual exam. Within a few days, her doctor called to explain that her Pap test was abnormal. “I thought it was a mistake,” said Cyd.  

Research Program

Research Interests

Investigative Therapy

Selected Publications

 Martin L, Schilder R. Novel approaches in advancing the treatment of epithelial ovarian cancer: the role of angiogenesis inhibition. J Clin Oncol. 2007 Jul 10;25(20):2894-901. PubMed

Martin LP, Hamilton TC, Schilder RJ. Platinum resistance: the role of DNA repair pathways. Clin Cancer Res. 2008 Mar 1;14(5):1291-5. PubMed. Review.

Additional Publications

Dr. Martin on My NCBI